Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (19)

2019

  1. Prognostic factors in neoadjuvant treatment followed by surgery in stage IIIA-N2 non-small cell lung cancer: a multi-institutional study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)

    Clinical and Translational Oncology, Vol. 21, Núm. 6, pp. 735-744

2018

  1. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society)

    Lung Cancer, Vol. 118, pp. 119-127

2017

  1. Neutrophil stunning by metoprolol reduces infarct size

    Nature Communications, Vol. 8

2016

  1. Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension

    Basic Research in Cardiology, Vol. 111, Núm. 4

2015

  1. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2

    Journal of the American College of Cardiology, Vol. 65, Núm. 14, pp. 1438-1450

  2. Impact of left ventricular hypertrophy on troponin release during acute myocardial infarction: New insights from a comprehensive translational study

    Journal of the American Heart Association, Vol. 4, Núm. 1

  3. Induction of sustained hypercholesterolemia by single adeno-associated virus-mediated gene transfer of mutant hPCSK9

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 35, Núm. 1, pp. 50-59

2014

  1. Response to letter regarding article, "effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of metoprolol in cardioprotection during an acute myocardial infarction (METOCARD-CNIC) trial"

    Circulation

  2. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes

    Basic Research in Cardiology, Vol. 109, Núm. 4

2013

  1. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: The effect of Metoprolol in Cardioprotection during an Acute Myocardial Infarction (METOCARD-CNIC) Trial

    Circulation, Vol. 128, Núm. 14, pp. 1495-1503

  2. Noninvasive monitoring of serial changes in pulmonary vascular resistance and acute vasodilator testing using cardiac magnetic resonance

    Journal of the American College of Cardiology, Vol. 62, Núm. 17, pp. 1621-1631

2012

  1. The future: Therapy of myocardial protection

    Annals of the New York Academy of Sciences, Vol. 1254, Núm. 1, pp. 90-98

2007

  1. Efecto de la atorvastatina sobre la expresión vascular de los PPAR en conejos dislipémicos

    Clinica e Investigacion en Arteriosclerosis, Vol. 19, Núm. 4, pp. 166-173

  2. Interactions between aldosterone and connective tissue growth factor in vascular and renal damage in spontaneously hypertensive rats

    Journal of Hypertension, Vol. 25, Núm. 3, pp. 629-638

2006

  1. Role of connective tissue growth factor in vascular and renal damage associated with hypertension in rats. Interactions with angiotensin II

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 7, Núm. 4, pp. 192-200

2005

  1. Eplerenone reduces oxidative stress and enhances eNOS in SHR: Vascular functional and structural consequences

    Antioxidants and Redox Signaling, Vol. 7, Núm. 9-10, pp. 1294-1301

2003

  1. Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits

    Clinical Science, Vol. 104, Núm. 4, pp. 357-365

  2. Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits

    Clinical Science, Vol. 105, Núm. 6, pp. 655-662

2001

  1. Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits

    Nephrology Dialysis Transplantation, Vol. 16, Núm. SUPPL. 1, pp. 40-44